SCHEMBL18055285

SCHEMBL18055285

CCC1CCCc2cc3c(cc2CC1)N(CCOC)C(=O)CC3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATAD2 Q6PL18 1/20 0.36
▸ CHRM1 P11229 10/20 0.34
▸ CHRM4 P08173 6/20 0.34
▸ CHRM5 P08912 6/20 0.34
▸ CHRM2 P08172 5/20 0.34
▸ DRD2 P14416 5/20 0.34
▸ CHRM3 P20309 5/20 0.34
▸ DRD4 P21917 5/20 0.34
▸ DRD3 P35462 5/20 0.34
▸ BRD4 O60885 1/20 0.33
▸ ADRB2 P07550 1/20 0.33
▸ ADRB1 P08588 1/20 0.33
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ ADRA1B P35368 1/20 0.33
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ NOS3 P29474 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14641644 0.85 ATAD2 (0.41) ATAD2CHRM1BRD4GRIN1GRIN2B
SCHEMBL12107604 0.77 ATAD2 (0.39) ATAD2CHRM1BRD4GRIN1GRIN2B
SCHEMBL12333333 0.72 ATAD2 (0.42) ATAD2CHRM1CHRM4CHRM5CHRM2
SCHEMBL12110139 0.69 ESR2 (0.44) GRIN1GRIN2B
SCHEMBL18421351 0.68 ATAD2 (0.72) ATAD2CHRM1CHRM4CHRM5CHRM2
SCHEMBL18055305 0.68 REN (0.42) RENCYP3A4
SCHEMBL12110391 0.67 GRIN1 (0.34) ATAD2CHRM1CHRM4CHRM5CHRM2
SCHEMBL12110145 0.67 CHRM1 (0.35) ATAD2CHRM1CHRM4CHRM5CHRM2
SCHEMBL2061080 0.66 ATAD2 (0.60) ATAD2CYP1A2CYP11B1CYP11B2SMN1; SMN2
SCHEMBL2060542 0.66 ATAD2 (0.47) ATAD2BRD4CYP1A2RENSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2546255-B1 BENZAZEPINE COMPOUND ASTELLAS PHARMA INC (JP) 2016-08-31 — — EP disclosed
Send feedback